Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
This paragraph explains how to identify dividend ETFs with the lowest management fees and compare options side by side.
27,460 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Catena Labs, led by Circle cofounder Sean Neville, closes a $30 million Series A to expand AI-driven payments tools a...
Zcash (ZEC) rose 27% in the last seven days, lifting its market profile as investors weigh a path into the crypto mar...
The idea of lenders relaxing standards to resemble pre-2008 days is making waves. This in-depth guide explains what t...
Cisco stock has surged about 32% in the past 30 days as AI infrastructure demand climbs; Arista slid 10% and Broadcom...
A personal-finance story about a costly legal battle forces a rethink on whether to accept a partner's financial supp...
The in-flight internet race is heating up. As Starlink expands across fleets, American Airlines could gain a meaningf...
AI is accelerating frontline work even as executive teams struggle to adapt. Leaders must redesign decision-making to...
U.S. homeowners hold record equity, but rising borrowing costs and cautious finances are keeping many from drawing on...
SpaceX is entering the IPO spotlight, but valuing a space, AI, and satellite powerhouse is unique. This guide breaks ...
NVIDIA CEO Jensen Huang positioned the latest AI stock pullback as a buying opportunity, a stance that reminds invest...
An overlooked defense contractor pivots to AI, turning years of skepticism into a rising star in enterprise AI and de...